- Filed
- May 5, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 28, 2026 | 50.4M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 49.9M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 49.95M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $9.98M |
| Capex | Q1 2026 · Mar 31, 2025 | $3.17M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $3.74M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$4.34M |
| Short Term Investments | Q1 2026 · Mar 31, 2026 | $130.72M |
| Short Term Investments | Q1 2026 · Dec 31, 2025 | $160.71M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $272.91M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $250.49M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $36.1M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2024 | $34.14M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $494.99M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $502.64M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $398.81M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $401.9M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $224.87M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $219.02M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $268.62M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $262.35M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $470.54M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $476.17M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $763.61M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $764.99M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.25 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.28 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.25 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.28 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $27.62M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $21.9M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $3.91M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $3.93M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$10.54M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$11.98M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$9.61M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$7.19M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $21.91M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $18.64M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $25.89M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $22.4M |
| Revenue | Q1 2026 · Mar 31, 2026 | $47.8M |
| Revenue | Q1 2026 · Mar 31, 2025 | $41.04M |